Drug companies are looking at Omicron-specific vaccines and boosters, but should we wait or get a shot now? A medical expert weighs in.
About 50% of eligible Americans have received a booster shot, according to the US Centers for Disease Control and Prevention, but the Pfizer and Moderna news might raise questions regardless.
Individuals who are vaccinated and also recovered from infection appear to have a very high degree of immune protection. The immunity from recovery is variable, though. Someone who became very ill may have a stronger antibody response compared with someone who had an asymptomatic infection, and we don't know how long that immunity lasts. That's why boosters are still recommended for people who have had Covid-19.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Clinical Trials Begin For Pfizer And BioNTech’s Omicron-Specific Covid ShotI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Les mer »
Pfizer begins testing omicron-matched COVID shots in adultsPfizer is enrolling healthy adults to test a reformulated COVID-19 vaccine that matches the hugely contagious omicron variant, to see how it compares with the original shots.
Les mer »
Pfizer launches study of omicron-specific COVID-19 vaccineBoosters still protect against severe disease.
Les mer »
Pfizer opens study of COVID shots updated to match omicronThe original vaccines still offer good protection against severe illness and death. Studies in the U.S. and elsewhere have made clear that adding a booster dose strengthens that protection and improves the chances of avoiding a milder infection.
Les mer »
Pfizer, Moderna shots safe during in vitro fertilization; healthy gut bacteria may help prevent long COVIDThe following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.
Les mer »
Moderna starts trial on omicron-specific Covid booster in adultsModerna starts its clinical trial using an omicron-specific booster vaccine. Pfizer has also started testing a vaccine for omicron.
Les mer »